Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments. (2021)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers13174460
PubMed Identifier: 34503270
Publication URI: http://europepmc.org/abstract/MED/34503270
Type: Journal Article/Review
Volume: 13
Parent Publication: Cancers
Issue: 17
ISSN: 2072-6694